Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Deflan Tablets
- Development stage
- Unknown
- Lead developer
- Wilson Drugs & Pharmaceuticals
- Administration
- Oral
01
Overview
Deflan Tablets is an Ayurvedic patent herbal antacid formulation developed by Wilson Drugs & Pharmaceuticals. It is formulated to manage gastrointestinal discomforts such as dyspepsia, hyperacidity, flatulence, and heartburn. The tablets contain a synergistic blend of traditional Ayurvedic ingredients, including Mulethi (Glycyrrhiza glabra), Dadima (Punica granatum), Triphala, Shankha Bhasma, and Sarji Kshara. These components work together to neutralize excess stomach acid, soothe the mucosal lining of the digestive tract, and promote overall digestive health.
- Brand names
- Deflan Tablets
Beyond the preview
Go deeper on Deflan Tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Deflan Tablets.